clinically distinct designation

Market Access

Payers worldwide are struggling with a new generation of precision medicines that come with a hefty price tag.

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.